About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Registry of Patients With MPNs in Taiwan | Clinical Trials | Clareo Health

Back to clinical trial search

Active Not RecruitingNCT03618485

Registry of Patients With MPNs in Taiwan

Myeloproliferative neoplasms (MPNs) are a group of clonal hematologic malignancies with great variation in reported patient life expectancy and are characterized by a relatively indolent course which ...

Lead sponsor: Chang Gung Memorial Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Chang Gung Memorial Hospital

Age

20 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Male and female patients aged ≥ 20 years.
•2. Patient who had a confirmed diagnosis according to the 2016 revised WHO criteria with a Ph (-) MPN.

Exclusion Criteria

•1. Patients do not fulfill the diagnostic criteria of MPN by WHO 2016 classification.
•2. Patients unwilling to sign informed consent.

Related studies

RECRUITINGPhase 1

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

NCT05936359 · Myeloproliferative Neoplasms

RECRUITINGPhase 2

A Phase 2 Study Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative Neoplasm

NCT06597734 · Chronic Myelomonocytic Leukemia, Advanced Myeloproliferative Neoplasms, and more

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

NCT00935090 · Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders, and more

Registry of Older Patients With Cancer

NCT01137825 · Chronic Myeloproliferative Disorders, Cognitive/Functional Effects, and more

RECRUITINGPhase 2

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

NCT03314974 · Acute Leukemia, Acute Myeloid Leukemia, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 14, 2025Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

Phase—

Enrollment500

Start dateApr 2017

Last updatedFeb 14, 2025

Condition

Myeloproliferative Neoplasms

Locations shown

Chang Gung Memorial Hospital-Linkou

Taoyuan District, State

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 14, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions